SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

IceCure Medical Ltd (ICCM) News

Track canonical SquawkNews coverage tagged to ICCM, IceCure Medical Ltd. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 21 indexed stories across 15 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol ICCM Asset equity Sector Markets 90 days 13 Last 1.74 Updated Sep 18, 2026, 11:09 AM UTC Open live news feed
H Full Transcript: Icecure Medical Q2 2026 Earnings Call Icecure Medical (NASDAQ: ICCM ) released second-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. This content is powered APIs. For comprehensive financial data and t LIVE | Sep 18, 2026, 11:09 AM UTC L IceCure Medical wins China approval for ProSense cryoablation system Content provided by Seeking Alpha is intended for information purposes only, and that Seeking Alpha does not offer any personalist investment advice and is not a licensed securities dealer, broker, US investment adviser GEOPOLITICS | Sep 10, 2026, 01:01 PM UTC L IceCure Medical gets regulatory approval to market ProSense in China REGULATION | Sep 10, 2026, 11:59 AM UTC L IceCure signs exclusive Netherlands distribution agreement IceCure signs an exclusive distribution agreement for ProSense cryoablation systems in the Netherlands. MNA | Aug 24, 2026, 11:50 AM UTC L ICCM Icecure signs exclusive Netherlands distribution deal for prosense® ICCM Icecure has signed an exclusive distribution agreement for its prosense® cryoablation systems in the Netherlands. MNA | Aug 24, 2026, 11:50 AM UTC L West Cancer Center receives IRB approval for IceCure ChoICE study ICCM says West Cancer Center received IRB approval to commence IceCure’s ChoICE study for breast cancer cryoablation. EQUITY | Aug 20, 2026, 12:10 PM UTC L IceCure (ICCM) highlights two peer-reviewed cryoablation publications IceCure (ICCM) highlights two new peer-reviewed publications supporting cryoablation in breast cancer treatment de-escalation, according to TradeXchange Newsdesk. EQUITY | Aug 13, 2026, 01:10 PM UTC H ICCM Reports 45% Revenue Growth ICCM reports 45% revenue growth year-over-year for the first half of 2026 EQUITY | Aug 12, 2026, 12:30 PM UTC M IceCure Medical Adds Adventist Health IceCure adds clinical site for breast cancer study EQUITY | Aug 06, 2026, 12:05 PM UTC L ICCM - IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 ICCM - IceCure Medical to Report First Half 2026 Financial and Operating Results on August 12, 2026 EQUITY | Aug 05, 2026, 12:30 PM UTC L ICCM ICCM - IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of Pro ICCM ICCM - IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance of ProSense® REGULATION | Jul 29, 2026, 12:25 PM UTC L IceCure Medical Notes Growing International Interest In Its ProSense System In Brazil Growing physician interest and commercial adoption for ProSense™ in Brazil's expanding interventional oncology markets increased following FDA authorization Independent study evaluating breast cancer cryoablation in 750 RATES | Jul 06, 2026, 12:14 PM UTC L IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer IceCure Highlights Expanding Commercial Adoption of Pro REGULATION | Jul 06, 2026, 12:12 PM UTC H 12 Health Care Stocks Moving In Friday's Intraday Session Gainers INVO Fertility (NASDAQ: IVF ) shares moved upwards by 67.3% to $2.08 during Friday's regular session. The market value of their outstanding shares is at $2.2 million. The company's, Q1 earnings came out 4 days ag EARNINGS | Jun 26, 2026, 05:05 PM UTC M ICCM Falls 11% IceCure Medical stock falls 11.97% despite regaining Nasdaq compliance EQUITY | Jun 26, 2026, 02:00 PM UTC L ICCM Files F-3 ICCM files Form F-3 for up to 5,500,002 ordinary shares EQUITY | Jun 25, 2026, 08:31 PM UTC L ICCM Regains Compliance IceCure regains compliance with Nasdaq minimum bid price requirement REGULATION | Jun 25, 2026, 12:12 PM UTC M 12 Health Care Stocks Move Twelve health care stocks are moving in Wednesday's intraday session, with Pulsenmore and Icecure Medical leading the gainers and Aditxt and Atlantic International among the losers EQUITY | Jun 24, 2026, 05:05 PM UTC L ICCM: Cryoablation Tops RFA IceCure highlights a new peer-reviewed journal article demonstrating cryoablation's advantages over radiofrequency ablation for early-stage breast cancer EQUITY | Jun 23, 2026, 12:11 PM UTC H Small Caps Surge Several small cap stocks are experiencing significant gains premarket due to various positive news announcements EQUITY | Jun 22, 2026, 12:21 PM UTC L ICCM Hits Premarket Highs ICCM reaches premarket highs EQUITY | Jun 22, 2026, 11:11 AM UTC